Provided by Tiger Trade Technology Pte. Ltd.

Gilead Sciences

143.72
-1.0900-0.75%
Post-market: 143.58-0.1428-0.10%19:30 EDT
Volume:4.20M
Turnover:605.07M
Market Cap:178.31B
PE:-54.96
High:145.99
Open:145.24
Low:143.50
Close:144.81
52wk High:157.29
52wk Low:108.46
Shares:1.24B
Float Shares:1.24B
Volume Ratio:0.77
T/O Rate:0.34%
Dividend:3.22
Dividend Rate:2.24%
EPS(TTM):-2.6150
EPS(LYR):6.78
ROE:-20.68%
ROA:14.09%
PB:15.07
PE(LYR):21.20

Loading ...

European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status

THOMSON REUTERS
·
Aug 24

Funds: What a Top Biotech Fund is Buying Now

Dow Jones
·
Aug 22

Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60

Reuters
·
Aug 22

Moderna Inc. Stock Advances 8.9%, Outperforms Peers

Dow Jones
·
Aug 22

Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit

Reuters
·
Aug 22

Movement Alert|Gilead Sciences Rises 3.07% in Regular Trading, $7.8 Billion Arcellx Acquisition Combined with Q2 Beat Continues to Lift Shares

Market Focus
·
Aug 21

Gilead (GILD) Stock Still Looks Below Fair Value As Court Backs HIV Import Block

Simply Wall St.
·
Aug 21

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 21

Moderna Inc. Stock Slips 23.5%, Underperforms Peers

Dow Jones
·
Aug 21

Moderna Inc. Stock Rallies 177.0%, Outperforms Peers

Dow Jones
·
Aug 20

Movement Alert|Gilead Sciences Rises 3.15% in Regular Trading, $7.8 Billion Arcellx Acquisition Continues to Lift Sentiment

Market Focus
·
Aug 19

What This Top Biotech Fund is Buying Now

Dow Jones
·
Aug 19

Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Disposes of USD 3.86 Million in Common Shares

Reuters
·
Aug 19

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 19

Gilead Sciences Inc Stock (GILD) Moved Up by 3.14% on Aug 18: Drivers Behind the Movement

TradingKey
·
Aug 19

Movement Alert|Gilead Sciences Rises 3.05% in Regular Trading, Announces $7.8 Billion Acquisition of Arcellx to Bolster Oncology Pipeline

Market Focus
·
Aug 18

BMO Capital Reaffirms Their Buy Rating on Gilead Sciences (GILD)

TIPRANKS
·
Aug 18

Gilead Sciences Earnings Call Highlights Strong Core Growth

TIPRANKS
·
Aug 17

Assembly Climbs on Quarterly Revenue Beat

Reuters
·
Aug 14

Mubadala Investment Co Pjsc Reports Share Stake in Ford Motor, Phillips 66, Dissolves in Apple

Reuters
·
Aug 14